RBC Capital analyst Brian Abrahams expects an imminent announcement on a new Gilead Sciences (NASDAQ: GILD) CEO, which will drive ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE